THYMOMA
Clinical trials for THYMOMA explained in plain language.
Never miss a new study
Get alerted when new THYMOMA trials appear
Sign up with your email to follow new studies for THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare chest cancer patients after other treatments fail
Disease control Recruiting nowThis study is testing whether a drug called sacituzumab govitecan can help control advanced thymoma or thymic cancer that has worsened despite previous treatment. It will involve 18 adults who receive the drug through an IV every three weeks. Researchers will check if tumors shri…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug duo tested for rare chest cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, tislelizumab and anlotinib, can help control thymoma or thymic carcinoma in patients whose cancer has grown despite initial chemotherapy. It will enroll about 20 adults in China to see if the treatment is safe and effectiv…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Scientists gather cancer clues in major tissue bank
Knowledge-focused Recruiting nowThis study aims to collect blood, urine, and tumor samples from up to 1,000 patients with mesothelioma and other related cancers. The purpose is to build a tissue bank for future research to better understand these diseases. Participants will be followed over time to track their …
Matched conditions: THYMOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC